Corning Elplasia Technology
With the effectiveness of 3D spheroids in many areas of research including anti-cancer drug screening and in vitro tumor studies, the need for better methods to produce replicate spheroids of uniform size in mass quantities has emerged.
Corning’s Elplasia technology addresses this need by enabling researchers to generate a high density of spheroids in a scaffold-free model using microcavity technology. Corning Elplasia technology is compatible with many cell types and may be used across many applications including; drug screening, cancer/tumor biology, stem cell biology, cell therapy research and 3D tissue engineering.